Refresh
X
Gainers
Losers
Sectors
Indices
Forex
Mutual Funds
Home
Indices
Sectors
Mutual Funds
Gainers
Losers
Forex
Investment Tool
All Pages
Dr. Reddy's Laboratories Ltd.
BSE
Price on BSE
22 Jan,11:40 LIVE
1,220.10
+64.60
(+5.59%)
© 2026 Rediff.com
Volume :
407,029.00
Prev Close :
1,155.50
Day's H/L (Rs.) :
1,224.25 - 1,188.95
52wk H/L (Rs.) :
1,377.95 - 1,025.90
Mkt Cap (Rs. Cr) :
101,829.55
NSE
Price on NSE
22 Jan,11:57 LIVE
1,222.50
+65.30
(+5.64%)
© 2026 Rediff.com
Volume :
3,611,442.00
Prev Close :
1,157.20
Day's H/L (Rs.) :
1,224.50 - 1,187.70
52wk H/L (Rs.) :
1,379.70 - 1,020.00
Mkt Cap (Rs. Cr) :
0.00
View more
Market News
Domestic sales a booster dose for pharma revenues
Rediff.com
2 day(s) ago
Dr Reddy's Laboratories loses Rs 2.16 cr in cyber fraud
Rediff.com
10 Nov 2025
'India Should Move Quickly As Conditions Change'
Rediff.com
02 Jan 2026
Weightloss Drugs Hit 1,000 Crore Mark
Rediff.com
22 Dec 2025
'14+ Anti-Obesity Drugs In The Pipeline'
Rediff.com
13 Dec 2025
Report Card - Dr. Reddy's Laboratories Ltd.
PE Ratios
18.01
EPS (Rs.)
64.14
Sales (Rs. Cr)
4,618.60
Face Value (Rs.)
1
Net Profit Margin(%)
23.14
Last Bonus
1:1
Last Dividend(%)
800
Return on Average Equity
18.53
News for Dr. Reddy's Laboratories Ltd.
Dr Reddy''s Q3 Profit Dips 14% to Rs 1,210 Cr
Dr Reddy''s Q3FY26 profit declines 14% to Rs 1,210 crore due to lower US sales. Revenue rises to Rs 8,727 crore. India sales up 19%.
Jan 21, 2026 18:20
Dr Reddy''s & Immutep Ink Cancer Drug Licensing Pact
Dr Reddy''s and Immutep collaborate to develop and commercialize Eftilagimod Alfa (Efti), a cancer medication, outside key markets.
Dec 08, 2025 14:49
Dr Reddy''s Biosimilar Approved in Europe
Dr Reddy''s gets EU nod for AVT03, a biosimilar of Prolia (denosumab) and Xgeva, used to treat osteoporosis and prevent bone complications.
Nov 24, 2025 17:22
Dr Reddy''s Srikakulam Unit Gets USFDA VAI
Dr Reddy''s Srikakulam facility gets Voluntary Action Indicated (VAI) status from USFDA after inspection. Inspection officially closed.
Oct 21, 2025 12:46
Glenmark, Dr Reddy''s Recall Products in US: USFDA
Glenmark and Dr Reddy''s recall products in the US due to manufacturing issues, says USFDA. Recalls include oral contraceptives and muscle relaxants.
Oct 19, 2025 10:20
More News for Dr. Reddy's Laboratories Ltd. »
News for Pharmaceuticals and health care
PhonePe IPO: Walmart, Tiger Global to Offload Stakes
Walmart, Tiger Global, Microsoft Global Finance to offload stakes worth Rs 10,000 cr in PhonePe IPO. IPO is entirely an Offer-for-Sale.
Jan 22, 2026 11:44
PhonePe IPO: Walmart, Tiger Global to Offload Stakes
Walmart, Tiger Global, Microsoft Global Finance to offload stakes worth Rs 10,000 cr in PhonePe IPO. IPO is entirely an Offer-for-Sale.
Jan 22, 2026 11:44
Nasscom Budget Wishlist: Tax Clarity, ESOP Deferment
Nasscom seeks cloud tax clarity, ESOP tax deferment for startups in Union Budget. Also requests carry-forward of losses for all companies.
Jan 22, 2026 11:16
AI Governance & Trust: Nasscom VP on Tech Future
Nasscom VP Ashish Aggarwal discusses India's AI governance approach, trust in tech, deepfakes, digital frauds, and technology-led guardrails.
Jan 22, 2026 11:11
India: From Emerging to Pivotal Economic Force
Indian ministers at Davos discuss India's transformation to a pivotal global economic force driven by growth and digital infrastructure.
Jan 22, 2026 10:45
More News »
Top News
PhonePe IPO: Walmart, Tiger Global to Offload Stakes
Walmart, Tiger Global, Microsoft Global Finance to offload stakes worth Rs 10,000 cr in PhonePe IPO. IPO is entirely an Offer-for-Sale.
Jan 22, 2026 11:44
PhonePe IPO: Walmart, Tiger Global to Offload Stakes
Walmart, Tiger Global, Microsoft Global Finance to offload stakes worth Rs 10,000 cr in PhonePe IPO. IPO is entirely an Offer-for-Sale.
Jan 22, 2026 11:44
Nasscom Budget Wishlist: Tax Clarity, ESOP Deferment
Nasscom seeks cloud tax clarity, ESOP tax deferment for startups in Union Budget. Also requests carry-forward of losses for all companies.
Jan 22, 2026 11:16
AI Governance & Trust: Nasscom VP on Tech Future
Nasscom VP Ashish Aggarwal discusses India's AI governance approach, trust in tech, deepfakes, digital frauds, and technology-led guardrails.
Jan 22, 2026 11:11
India: From Emerging to Pivotal Economic Force
Indian ministers at Davos discuss India's transformation to a pivotal global economic force driven by growth and digital infrastructure.
Jan 22, 2026 10:45
More Top News »
Sectoral Indices
Market Indicators
Listed Companies
Gainers
Losers
Mutual Funds
Portfolio
Watchlist